Table 4.
Clinical and pathologic characteristics of ovarian cancer patients.
Characteristics | Olaparib n (%) |
Niraparib n (%) |
---|---|---|
Total | 14 | 24 |
Histology | ||
High grade serous adenocarninoma | 12 (86%) | 24 (100%) |
Endometrioid carcinoma | 2 (14%) | 0 |
Response to platin | ||
Complete response | 5 (36%) | 8 (33%) |
Partial response | 7 (50%) | 14 (58%) |
Stable disease | 2 (14%) | 2 (9%) |